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ABSTRACT 
 
Background  
This is an epidemiological descriptive study of pregnant women or girls 
in 2008 who are living with HIV or Syphilis diagnosis, and the outcome of 
their offspring after the 18 month follow-up period in the Republic of 
Panama. HIV and Syphilis are sexually transmitted diseases, and have been 
used as an indicator of sexual risk behavior; as more women get infected in 
reproductive ages, unborn fetuses are more at risk to get any of these 
diseases.  
Despite all the efforts in the Latin American Region and the Caribbean 
(LAC), by 2010 LAC was the most affected world region for Congenital 
Syphilis and the third most affected for HIV/AIDS. Due to the lack of 
information about vertical transmission of HIV and syphilis we considered it 
necessary to conduct a baseline clinical chart review to identify the 
prevalence of young positive females and the outcomes on their offspring in 
the Republic of Panama. 
Methods  
The study collected data for 2008 from secondary sources of 
information: bulletins of epidemiologically surveillance of the ministry of 
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health, birth records, and miscarriage records.  The study compared the 
outcome of the pregnancies with the data available in the Children’s Hospital 
clinical charts (the national anti-retroviral therapy clinic for children) and 
“Albergue de Maria” (a non-governmental organization that provides care to 
orphans).   
Results 
The current study found 290 clinical charts from pregnant women or 
girls who were living with HIV/AIDS in 2008 and prenatally exposed children 
to HIV born between January 2008 and September 2009. There were more 
clinical charts of prenatally exposed children (174) than pregnant women or 
girls (116). 
The clinical charts from the 2008 pregnant women and girls living with 
HIV/AIDS revealed that most of the cases are located in the metropolitan 
health region, followed by San miguelito and Colon. During the 2008 
pregnancy 81.67% received HAART, the viral load test result was available in 
41.67% of the cases prior to delivery, and 28.33% of the cases had viral load 
count below 1000 copies, and 83.33% of the pregnancies ended in a live 
birth.  
During pregnancy 58.05% of the mothers received HAART, and 
68.39% received intravenous zidovudine during labor. The 81.03% of the 
offspring’s received oral zidovudine the following six weeks after birth, and 
54.02% were feed with infant-adapted formula. During the follow-up period 
12.64% were diagnosed as positive and 36.36% of the HIV positive children 
had an older seropositive sibling. 
vii 
 
Variables such as receiving HAART during pregnancy, intravenous 
zidovudine during labor, being born through caesarean, receiving oral 
zidovudine the following six weeks after birth, and been feed with infant-
adapted formula are variables statistically significant when compared to the 
dependent variable final diagnosis of the prenatally exposed children to HIV. 
Conclusions 
The Republic of Panama has made efforts to face Mother-to-Child HIV 
transmission. The current study shows the improvements on availability and 
proper usage of medications to avoid mother-to-child HIV transmission, 
laboratory tests to diagnose pregnant females and children, and the free 
provision of formula-adapted milk; as well as opportunities for improvement 
such as the late start date of prenatal control and laboratory testing, 
availability of viral load results prior to delivery, and determining the delivery 
method of the pregnant women.   
This information will contribute to the ministry of Health to draft 
strategies to achieve the UNAIDS goal of zero HIV-positive children 
secondary to perinatal exposure and zero new cases of HIV by 2015. 
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CHAPTER ONE: INTRODUCTION 
 
Panama is a country located in Central America; it is the isthmus that 
connects North and South America. The country is mostly known because of 
the Panama Canal, its watershed and harbor-related activities. Because of 
the abundant economic opportunities, more than half of the population lives 
around the Panama Canal Area. 
Panama has been divided into 14 health regions, five of which are 
located near the Panama Canal area (Metropolitan Region, San Miguelito 
Region, Colon Region, East and West Panama Region). Within these five 
regions, the two main ports of Panama are located.  Due to the nature of the 
activities related to ports there are mobile populations, uniformed forces and 
female and male sex workers, all populations identified as ‘Most-At-Risk 
Population’.   
The rate of women with HIV/AIDS was 2.4/100,000 in 1993 and by 
2010 it was 30.2/100,000 females (Epidemiology, 2011), and the proportion 
of HIV positive children secondary to vertical transmission (between 0.4 and 
0.9) were located in the health regions by the Panama Canal area and the 
shores (Epidemiology, 2011). 
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For 2010 there was an estimated 0.3% (N = 189) seropositivity in 
pregnant women, which means that for every 1,000 pregnancies there were 
3 positive pregnant women living with HIV. From those 189 pregnant women 
in 2010 the national department of epidemiology only has the data on 57 
deliveries: 24 of them were vaginally delivered (Epidemiology, 2011). There 
is no data about the circumstances of the delivery and lack of information 
about the immunological status of the newborns perinatal exposed to HIV. 
The first case of congenital syphilis was recorded in 1984, and since 
then there have been 452 reported cases, with a mean of 17 cases per year 
and a stable rate of 0.3 (Department of Epidemiology, 2010).  The highest 
rates of congenital syphilis are found in the Metropolitan health region, San 
Miguelito, and the West Panama Region; coincidentally these are three of the 
five health regions that report the highest rates in HIV/AIDS. 
HIV and Syphilis are both sexually transmitted diseases, and have 
been used as a predictor of sexual risk behavior.  The presence of the 
characteristic sore (chancre) of syphilis might increase up to five times the 
risk of transmission of HIV (Gray, et al., 2001).   
In efforts to control HIV/AIDS and congenital syphilis in 2007, Panama 
developed guidelines for the therapeutic management of people living with 
HIV and syphilis during pregnancy, including guidelines for improving the 
care of pregnant women. In 2009 the National Plan for multisectoral 
prevention of mother to child transmission of HIV and syphilis in Panama  
3 
 
were published; both publications emphasized the screening with rapid tests 
for HIV and non treponemic tests on two occasions during pregnancy: before 
the 20th week and in the third trimester of pregnancy. Those guidelines state 
that after a pregnant woman is detected positive she should be referred to a 
high-risk obstetrics clinic for follow-up and programming of a caesarean and 
then referred to a antiretroviral therapy clinic (ARVTC) for immune 
monitoring, initiation of ARVT with a scheme including AZT.  If the presence 
of active syphilis is detected, the treatment can be applied at a primary care 
center, to her and the sexual partner, free of charge. 
The purpose of this epidemiological descriptive study is to provide 
baseline information, utilizing clinical charts of seropositive women who have 
been pregnant and/or had congenital syphilis during 2008 to discover the 
resulting outcomes of the pregnancy and if the national guidelines on 
HIV/AIDS and Gestational Syphilis for pregnant women are being followed in 
the Republic of Panama. Another goal is to identify potential avenues for 
strengthen the Panamanian Health Service. 
 
Objectives 
General objective 
Provide concrete epidemiological knowledge about the situation of 
mother-to-child HIV transmission and congenital syphilis in Panama to 
develop programmatic strategies to eradicate mother-to-child HIV 
transmission and congenital syphilis. 
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Specific Objectives 
1. Identify women who were HIV positive and pregnant between 
January 1, 2008 until December 31, 2008. 
2. Describe epidemiological characteristics of pregnant women in 2008 
living with the diagnosis HIV and/or syphilis in Panama. 
3. Quantify the obstetric outcome (live birth, miscarriages and 
stillbirth) of pregnant women living with HIV and/or syphilis in 
2008. 
4. Describe compliance of the Panamanian National Guidelines to 
prevent mother-to-child transmission of HIV and/or syphilis in 
2008. 
5. Describe sero-positivity of children prenatally exposed to HIV, born 
between January 2008 and September 2009. 
6. Describe the outcome of newborns exposed to gestational syphilis, 
looking for early signs of congenital syphilis such as prematurity, 
intrauterine growth restriction, fever, and irritability, early or later 
rash or watery discharge from the nose, in a 30 day period after 
delivery. 
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CHAPTER TWO: BACKGROUND 
 
HIV/AIDS 
The first AIDS case was diagnosed in Panama in September 1984, and 
the most affected population were men who have sex with men (MSM) and 
hemophiliacs (Epidemiology, 2011). In 2010, 11,585 were diagnosed with 
AIDS and 6,419 with HIV, prevalence was estimated at 0.8%, and the male-
female ratio was 3:1 (Epidemiology, 2011).  The population between 25 and 
49 years of age were the most affected (69.7%). Panama has a concentrated 
type epidemic, where the most at risk population (MARPS) is over 5% (MSM: 
12.4%) and among pregnant women the risk is less than 1.0% (0.3%) 
(Epidemiology, 2011). 
The global summary of the AIDS epidemic states that there are 33.3 
million people infected with HIV; 92.49% (30.8 millions) are adults and from 
those 51.62% (15.9 millions) are women (UNAIDS, 2011).  Over the years 
HIV / AIDS has suffered a feminization and rejuvenation: 6,000 new 
infections of HIV are taking place per day in adults, 51% are women, and 
41% are people between 15 and 24 years old (UNAIDS, 2011). In Panama 
since 1993 the incidence in women has increased from 2.4/100,000 up to 
30.26/100,000 in 2010 (Epidemiology, 2011). Similarly, in the same period  
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incidence has doubled in people less than 24 years of age: from less than 5% 
in 1993 to 9.1% in 2010. In this age group the male-female ratio is 1:1.7 
meaning, there are two women for every man in this age group 
(Epidemiology, 2011).  
HIV can be mainly transmitted by unprotected sexual contact, by 
sharing contaminated needles, maternal-to-child transmission, and is less 
likely to be transmitted due to blood transfusion or organ transplantation 
(American Academy of Pediatrics, 2012).  In Panama the transmission 
mechanisms described in 2010 were: sexual contact with 67.0% (12.4% 
homosexual, 3.8% bisexual and 50.8% heterosexual), blood transmission in 
1.2% (0.2% blood recipients, 0.1% hemophiliacs, intravenous drug users 
0.9%) and perinatal transmission was reported in 3.0%. There is also a 
quarter of the population with unknown mechanism of infection (26.7%) 
(Epidemiology, 2011). 
The risk of mother to child transmission or perinatal transmission of 
HIV can occur during pregnancy (in utero from 25 up to 40% of the time), 
during labor and delivery (60-75%) and through breastfeeding (15-30%) 
(World Health Organization, 2011). The first data on the perinatal 
transmission in Panama was described in 1998 in 14% (Nieto, 2006), but 
after the introduction of Zidovudine (AZT) on the Panamanian regimen of 
pregnant women living with HIV/AIDS in 2002, mother to child transmission 
was reduced to 5% in 2008, and described as 3.0% in 2010 (Epidemiology, 
2011). 
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Congenital Syphilis 
Treponema pallidum is a spirochete bacterium that transmits syphilis. 
It was first described between 1493 and 1495 during an outbreak in Italy, 
but the agent was recognized in 1905 using the dark ground microscopy.  
Due to the discovery of penicillin and its effectiveness to treat syphilis, the 
incidence of the disease declined during the 19th and 20th centuries (Quetel, 
1992).  Surprisingly, the rate of these STDs has been increasing in the last 
century, affecting pregnant women and their unborn children. 
The problem was addressed as a Public Health Problem in Latin-
American countries since 1994 during the XXIV Pan-American Sanitary 
Conference.  During the 116th executive board meeting in 1995 (Pan-
American Health Organization, 2010), wrote a document in which they 
designed an action plan, methodology and strategies to achieve the 
elimination of congenital syphilis.  The rate of congenital syphilis in Panama 
by that date was 0.6/1000 live births and the Latin American region was the 
region with the second highest sero-prevalence worldwide with 3.9% (range 
from 0.7% to 7.4%) (Department of Epidemiology, 2010); the most affected 
region is sub-Saharan Africa (World Health Organization, 2011). 
The LAC is ranked the most affected region by congenital syphilis 
despite all the efforts held in the region to decrease the congenital syphilis, 
such as:  
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 Publication of frame reference for the elimination of congenital syphilis 
in the Americas in 2005 by PAHO 
 The ratification from regional ministers of health in favor of the 
elimination of congenital syphilis initiative in 2007 
 The publication of the basic documents for the elimination of 
congenital syphilis initiative in December 2009 that includes the clinical 
guidelines and the regional monitoring strategy  
By 2010, the Latin American region reached the highest rate of congenital 
syphilis worldwide (Pan-American Health Organization, 2010) and Panama 
reported a rate of 2.2/1000 live births (not including perinatal deaths 
secondary to in-utero exposure to syphilis) (Department of Epidemiology, 
2010). 
Syphilis is transmitted by unprotected sexual contact and during 
pregnancy from an infected mother to the fetus (American Academy of 
Pediatrics, 2012). Most of the times disease is transmitted during weeks 16 – 
28 that leads to miscarriage (30-50% of the cases) and other complications 
of the pregnancy that ranges from stillbirth, hydrops fetalis, intrauterine 
growth restriction and perinatal death (80%) (American Academy of 
Pediatrics, 2012) (Quetel, 1992). 
Congenital syphilis is the direct consequence of a mistreated sexually 
transmitted disease that has an inexpensive screening test and a low cost 
treatment.  Although health campaigns and publications available in the 
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region related to this topic, congenital syphilis continues with a positive trend 
(Pan-American Health Organization, 2010). 
 
Facing the Epidemic of Mother-to-Child HIV Transmission and 
Congenital Syphilis 
The 189 countries that signed the Millennium Development Goals 
(MDG) in 2000, Panama included, are committed to promote gender equity 
and empower women, to reduce infant mortality, to improve maternal health, 
and to combat HIV/AIDS, malaria and other diseases. Studying mother to 
child HIV transmission and Gestational Syphilis provides scientific information 
that will help to achieve the MDGs.  
The sanitary code of the Ministry of Health in its fifth article states that 
diseases which represent a major risk for Panamanian population should be 
notified immediately to the epidemiological department (Ministry of Health, 
1947).  Since 1994 the HIV/AIDS report form includes the name, 
identification number and the address. The HIV/AIDS report form was 
designed to strengthen the active epidemiological surveillance activities 
(Ministry of Health, 2003).  In 2000, the law number 3 addressed 
STD/HIV/AIDS as a national problem that should be addressed through 
education, prevention and early diagnosis.  The second chapter of the law, 
regarding prevention, in the article 6 related to early diagnosis, states that 
HIV test in pregnant women is mandatory, even if the women or girl doesn’t  
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want to know the result; the clinicians need the test results on behalf of the 
unborn children. The title 3 of the same law, article 45 states that any health 
care practitioner that doesn’t notify the presence of an HIV positive test 
might be sanctioned with two to five years in jail (Ministry of Health, 2000). 
In 2007, Panama developed a national multisectoral plan to prevent 
mother-to-child transmission of HIV and syphilis, which states that all 
pregnant women will receive integral attention free of charge, including 
prenatal control and screening tests. It says that in every medical record per 
each pregnancy two rapid HIV test and VDRL or RPR for syphilis should be 
reported.  Before week 20, and one month prior to the delivery, if there is no 
evidence of any of those tests in the prenatal chart, the physician should 
request one during labor to identify HIV and/or Syphilis in prenatally exposed 
cases and start treatment, it also states to refer pregnant women living with 
HIV/AIDS to antiretroviral clinics and high risk OB-GYN unit, they should 
receive counseling regarding the diagnosis to increase the adherence to 
treatment. The offspring’s of women living with HIV/AIDS needs to be feed 
with infant-adapted formula, for such reason the provision of such milk is 
free of charge (PTMI, 2010). 
MEGAS (Medicion y Analisis del Gasto en SIDA from the initials in 
Spanish) in 2008 reported 21,077,738 USD spent on HIV/AIDS programs. 
From those 12,154,872 USD (57.67%) were used to provide screening and 
treatment to prevent mother-to-child transmission of HIV and/or syphilis 
nationwide.  On prevention programs 8,233,218 USD (39.8%) was spent, 
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including the purchase of condoms. The money used for at risk children and 
orphans was 229,666 USD which represents 1.1% of the overall spent 
(USAID-PASCA, 2008). 
Due to the feminization and rejuvenation of STD/HIV/AIDS in Panama, 
key strategies need to be developed to strengthen the Panamanian response 
to HIV/AIDS. This study aims to identify the real scenario on vertical 
transmission of HIV and congenital syphilis in the Republic of Panama during 
the 2008-2011 period, to develop programmatic strategies to eradicate 
mother-to-child HIV transmission and congenital syphilis.    
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CHAPTER THREE: METHODS 
 
Design 
This is a non-experimental descriptive study that provides an 
epidemiological description retrospectively about pregnant women living with 
HIV/AIDS and those with gestational syphilis from January 1st, 2008 to 
December 31, 2008, as the outcome of prenatally exposed newborns to HIV 
(until the end of the 18 month follow up period March 2011) and congenital 
syphilis.  The study verified the information in the national epidemiological 
surveillance department of the Ministry of Health (electronic database in Epi-
info 2000, Centers for Disease Control and Preventions, Atlanta, GA, USA), 
and clinical charts from the Mother and Children Hospitals that provides for 
such patients (12 Antiretroviral Clinics for Adults, one pediatric clinic, and an 
orphanage). Because the study was looking to track the obstetric outcome 
and the serological child status after recommended test in these cases the 
data cycle was in a 27-month period. 
Our research question required the linkage of the data from clinical 
charts from HIV positive mothers and their offspring. The clinical charts were 
classified based on the Panamanian Country Resident Identification Number 
(CRIN). This CRIN is used for identification during any government 
interactions by all Panamanians; this includes healthcare. However, 
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precautions were taken, including but not limited to assigning a consecutive 
number to the actual health-related data collected (not the actual CRIN) and 
using a password protected linkage file with identifiers as described herein. 
In addition, the linkage file containing the identifiers was deleted after the 
data collection was completed at each site. The deletion of those identifiers 
at that time was to fulfill Panamanian law number 3 of January 2000. The 
data collection started once received clearance from the inter-institutional 
review board from Panama and the University of South Florida. 
 
Phases  
a. HIV and/or syphilis-positive pregnant cases were obtained from the 
statistics department, specifically the epidemiological surveillance of 
STD / HIV / AIDS of the Ministry of Health. The study got the 
epidemiological data of every case in 2008, such as age and date of 
the HIV diagnosis.  
b. The study audited the clinical charts of pregnant women diagnosed 
with HIV or syphilis from January 2008 to December 2008 from the 
ARVC looking for educational level, the trimester in which the prenatal 
control starts, the results of the screening test, compliance with the 
national guidelines to treat pregnant women living with HIV and/or 
syphilis, the outcome of the pregnancy and the date of the delivery, 
miscarriage or stillbirth.    
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c. After identifying the newborns exposed prenatally to HIV or syphilis 
from January 2008 to September 2009, the clinical charts from the 
national ARTC for children and from the orphanage “Albergue de 
Maria” were reviewed looking for information regarding the compliance 
with the national algorithm to treat such children, the delivery history 
(vaginal, caesarean-section, weight, breastfeeding), and also followed 
the evolution of the laboratory results of PCR DNA Pro-viral and ELISA 
after 18 months up to the final diagnosis of HIV and/or syphilis of the 
prenatally-exposed children.  
 
Sample Size 
Based on the national STD/HIV/AIDS surveillance department of the 
Ministry of Health in 2008 there were 153 pregnant women living with 
HIV/AIDS and girls and 32 cases of congenital syphilis.  There was 
incomplete information regarding the outcomes of the pregnancy or how 
many newborns were prenatally exposed to HIV and what their 
immunological statuses are. 
After the data collection phase was completed the study reviewed 290 
clinical charts: 174 from newborns prenatally exposed to HIV and Syphilis, 
and 116 belonging to pregnant women living with HIV/AIDS. 
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Inclusion and Exclusion Criteria 
Inclusion criteria 
1. Pregnant women and girls of any age for whom an HIV and/or 
syphilis test was reported as positive in the national epidemiological 
surveillance for STD/HIV/AIDS from the Ministry of Health of 
Panama from the January 1st, 2008 through December 31, 2008. 
2. Clinical charts available from pregnant women and girls of any age 
for whom an HIV and/or syphilis test was performed and positive 
results are found from the January 1st, 2008 through December 31, 
2008. 
3. Clinical charts available from infants prenatally exposed to HIV born 
between the January 1st, 2008 and September 31, 2009. 
 
Exclusion criteria 
1. Records from pregnant women and girls living with HIV/AIDS and 
children prenatally exposed to HIV not available during the data 
collection phase.  
Data Collection Instrument 
A survey data collection instrument was designed for the study. It was 
applied to the clinical charts only, with closed-ended answers. The study 
gathered:  
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 Socio-demographic data 
 Data of when an HIV or syphilis diagnosis of the mother was 
made 
 Compliance with the national guidelines of mother-to-child HIV 
transmission and congenital syphilis (initiation of antiretroviral 
therapy or antimicrobial therapy, laboratory testing during 
pregnancy, procedures for childbirth delivery, provision of milk 
formula and breastfeeding, referring to antiretroviral therapy 
clinic for both adult and newborns, counseling for adults about 
adherence to antiretroviral therapy in adults and newborns). 
 
Variables 
The study collected data from the clinical charts concerning each case 
of pregnant women and girls who receive an HIV and /or syphilis screening 
test which reported positive results in the national epidemiological 
surveillance for STD/HIV/AIDS in Panama during January 1st, 2008 up to 
December 31, 2008. All the variables were considered discrete for analysis 
purposes (Pan-American Health Organization, 2011). All the variables were 
considered categorical as listed in the code book. Variables were describe 
according to a regional initiative conducted by the Panamerican Health 
Organization to evaluate mother-to-child transmission of HIV and congenital 
syphilis. 
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Table 1. Investigated variables from pregnant women and girls living with 
HIV/AIDS 
# Variable name Variable definition Codes 
1 
 
Health_R Panama is divided by 14 
health regions; subjects 
were classified in any of 
those regions 
1. Bocas del Toro 
2. Chiriquí 
3. Coclé 
4. Colón  
5. Comarca Gnabe Bugle 
6. Comarca Guna Yala 
7. Darién 
8. Herrera 
9. Los Santos 
10. Panamá Este 
11. Panamá Metro 
12. Panamá Oeste 
13. San miguelito 
14. Veraguas 
-6=Missing 
2 DT_Birth Date of Birth Month/day/year  
3 Educ Number of years 
approved by the 
pregnant women or girl 
who filled the inclusion 
criteria to participate in 
the study 
1=LESS THAN FOUR 
YEARS                         
2= FIVE TO TEN YEARS                                    
3= MORE THAN TEN 
YEARS                           
6=  OTHER                                            
-6 = MISSING        
4 O_Educ Other Education   
5 START_PNC Trimester where the 
Pre-natal Control Starts 
1= First trimester (0-13 
w)                                                                 
2= Second Trimester 
(14-27 w)                                                                         
3= Third trimester (28-
41 w)                                            
-6 = MISSING                                      
6 VDRL/RPR Syphilis Test during 
Prenatal Control 
0=NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
7 VDRL/RPR_Res Syphilis Test during 
Prenatal Control Result 
0= Non-Reactive                                            
1= Reactive                                             
-6= Missing 
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8 VDRL/RPR_Tx Did the women receive 
treatment according to 
national guidelines 
0=NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
9 VDRL/RPR_Tx_P Did the partner receive 
treatment according to 
the national guidelines 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
10 Counselling Did they receive any 
counseling about STD 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
11 Condoms Did they receive 
condoms 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
12 HIV_Dx Was the HIV Diagnosis 
made during pregnancy 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
13 HIV_Trim In which trimester the 
HIV diagnosis was 
made? 
1= Before 20 w                                                                 
2= Greater or equal to 
20 w                                                                     
-6 = MISSING                                      
14 REF_ARVC Was the pregnant 
women or girl referred 
to a antiretroviral Clinic? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
15 REF_OBS Was the pregnant 
women or girl referred 
to a High Risk obstetric 
Clinic? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
16 HAART Did the women receive 
TARV according to 
national guidelines? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
17 Prior_Dx When was the diagnosis 
made 
  
18 Counseling_RR Did the women receive 
counseling about 
reproductive rights and 
sexual health? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
19 Planned_Preg It is reported that it was 
a planned pregnancy  
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
20 Change_ARV Did the physician 
change the ARV 
according to national 
guidelines 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
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21 VL_Req Was the Viral Load Test 
Requested? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
22 CD4_Req Was the CD4 Test 
Requested? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
23 VL_DD Was the Viral Load 
Result available at the 
delivery date? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
24 Viral_load 
below 1000 
copies 
Was the Viral Load 
Result below 1000 
copies? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
25 Date_outcome Date of Outcome  Month/day/year 
26 Outcome Which was the Outcome 
of the pregnancy? 
0= Abbortion                                                         
1= Misscarriage                                    
3= Stillbirth                                                            
4= Live birth                              
-6=Missing 
27 AZT_LB It is reported the use of 
AZT during labor on the 
live births? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
28 WAY_LV Way of delivery of the 
live birth? 
1= Vaginal Delivery                       
2= Emergency 
Caesarean                                                 
3= Programmed 
Caesarean                                    
-6= Missing 
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Table 2. Investigated variables from prenatally exposed children to HIV 
# Variable name Variable definition Codes 
1 
 
Health_R Panama is divided by 14 
health regions; subjects 
were classified in any of 
those regions 
1. Bocas del Toro 
2. Chiriquí 
3. Coclé 
4. Colón  
5. Comarca Gnabe Bugle 
6. Comarca Guna Yala 
7. Darién 
8. Herrera 
9. Los Santos 
10. Panamá Este 
11. Panamá Metro 
12. Panamá Oeste 
13. San miguelito 
14. Veraguas 
      -6=Missing 
# Variable name Variable definition Codes 
2 DT_Birth Date of Birth  Month/day/year 
3 Where The delivery was at the 
Hospital? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
4 37 weeks or 
above 
The gestational age at birth 
was 37 or above? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
5 W_A_B What was the weight at birth? 0= PEG                                                      
1= AEG                                                      
2= GEG                                                  
-6 = MISSING                                                                                   
6 WAY_LV What was the way of delivery 
of the live birth? 
1= Vaginal Delivery                       
2= Emergency Caesarean                                                 
3= Programmed Caesarean                                    
-6=Missing 
7 AZT_LV It is reported in the clinical 
chart the use of AZT during 
labor on live birth? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
8 HAART Did the women receive TARV 
according to national 
guidelines? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
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9 VL_DD Was the Viral Load result 
available on the delivery date? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
10 Viral_load below 
1000 copies 
Was the Viral Load Result 
below 1000 copies? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
11 Feeding_Hx What was the feeding history 
of the newborn? 
0= Formula                                         
1= Breastfeeding                             
3= Mixed                                             
-6= Missing 
12 AZT_P Did the newborn receive AZT 
prophylaxis per 6 weeks? 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
13 PCR_1 What was the result of first 
PCR or Pro-Viral DNA? 
0= Negative                                            
1= Positive                                              
-6= Missing 
14 PCR_2 What was the result of Second 
PCR or Pro-Viral DNA? 
0= Negative                                            
1= Positive                                              
-6= Missing 
15 ELISA_18M What was the result of ELISA 
test? 
0= Negative                                            
1= Positive                                              
-6= Missing 
16 Final_Dx What is the final diagnosis? 0= Negative                                            
1= Positive                                              
-6= Missing 
17 OTH_SIB Is there other Siblings with 
HIV Diagnosis 
0= NO                                                      
1= YES                                                       
-6 = MISSING                                                                                   
 
Analysis plan 
The study used a customized database in Microsoft ACCESS 2010 for 
Windows (Microsoft office, USA) to input the data.  The database was 
analyzed with SAS software version 9.3 (SAS Institute, Cary, NC, USA).  
Because the study was analyzing categorical variables, the information was 
summarized as frequencies, proportions and ratios. At the end of the data 
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collection phase the database was password-protected and encrypted to 
preserve its confidentiality. The encryption is an internal procedure of Access 
2010 (Microsoft office, USA) to encode the information included in a given 
dataset and make it unreadable for unauthorized users without the 
encryption key. This procedure was needed to ensure law number three of 
January 2000 (Ministry of Health, 2000). 
The data collected was used for further analysis and was group 
according to the type of answer coded. They were classified as frequencies, 
proportions and ratios. 
 
Frequencies  
1. Distribution of pregnant women or girls according to the start date of 
prenatal control. 
a. First Trimester 0 to 13 weeks 
b. Second Trimester 14 to 27 weeks 
c. Third Trimester 28 to 41 weeks 
2. Distribution of pregnant women and girls living with HIV/AIDS in 2008 
according to age range.  
a. 15-24 years 
b. >= 25 years 
c. 26 - 29 years 
d. >= 30 years 
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3. Distribution of Educational level among pregnant women and girls 
living with HIV/AIDS. 
a. <4 years;  
b. 4 to 10 years;  
c. >10 years approved  
4. Distribution of HIV positive test performed in pregnant women or girl 
a. Before or equal to 20 weeks of gestation 
b. 20 weeks and above of gestation 
5. Distribution of pregnant women and girls living with HIV/AIDS who 
received counseling about HIV and pregnancy. 
6. Distribution of syphilis in pregnant women or girls in 2008 according to 
age range.  
a. 15-24 years 
b. >= 25 years 
c. 26 - 29 years 
d. >= 30 years 
7. Distribution of educational level among syphilis positive pregnant 
women or girl. 
a. <4 years;  
b. 4 to 10 years;  
c. >10 years approved  
8. Geographical distribution among the 14 health regions in Panama of 
HIV cases among female pregnant women from January 2008 to 
December 2008. 
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9.  Geographical distribution among the 14 health regions in Panama of 
congenital syphilis cases among female pregnant women from January 
2008 to December 2008. 
10. Geographical distribution among the 14 health regions in Panama of 
HIV secondary to prenatal exposure among children born between 
January 2009 and September 2009 after the follow-up period (18 
months). 
11. Geographical distribution among the 14 health regions in Panama of 
congenital syphilis cases among children born between January 2008 
and September 2009 after the follow-up period. 
12. Distribution of obstetric outcomes among pregnant women living with 
HIV/AIDS reported between January 2008 and December 2008. 
a. Numerator # of specific obstetric outcome among pregnant 
women or girls living with HIV/AIDS between January 2008 and 
December 2008 
b. Denominator # of positive pregnant women and girls living with 
HIV/AIDS between January 2008 and December 2008. 
13. Distribution of the method of delivery among the pregnant women or 
girls living with HIV/AIDS with reported live births between January 
2008 and September 2009 
a. Numerator # of specific delivery method from the HIV positive 
women or girls between January 2008 to September 2009. 
b. Denominator # of HIV pregnant women or girls with a reported 
live birth. 
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14. Distribution of delivery assisted by health care personnel 
a. Numerator # of delivery assisted by health care personnel 
among HIV positive women or girls between January 2008 to 
September 2009. 
b. Denominator # of pregnant women or girls living with HIV/AIDS 
with a reported live birth. 
15. Distribution of birth weight among the live births among the 
prenatally exposed to HIV between January 2008 to September 2009 
16. Distribution of children prenatally exposed referred to a ARV Clinic 
 
Proportions 
17. Proportion of counseling for syphilis pregnant women or girl about 
STD. 
18. Proportion of pregnant women or girls that tested positive to HIV in 
which clinical chart is consigned the provision of condoms. 
19. Proportion of pregnant women or girls that tested positive to Syphilis 
that receive proper treatment, according to national guidelines. 
20. Proportion of pregnant women or girls with previous knowledge of 
being HIV positive. 
21. Proportion of pregnant women or girls that tested positive to HIV that 
receive proper treatment, according to national guidelines. 
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22.Proportion of gestational age (below 37 weeks vs above or equal to 37 
weeks) at delivery among the live births among the prenatally exposed 
to HIV between January 2008 to September 2009 
23. Proportion of type of feeding among prenatally exposed children born 
between January 2008 and September 2009 
c. Numerator # of Type of feeding (breastfeeding vs formula vs 
mixed) among children prenatally exposed children to HIV born 
between January 2008 and September 2009 
d. Denominator # of live births prenatally exposed to HIV born 
between January 2008 and September 2009 
 
Ratios 
24. Vertical transmission rate of HIV in children born from January 2008 
to September 2009 
e. Numerator: # of HIV positive children confirmed by ELISA at 18 
months of age 
f. Denominator: # of live births prenatally exposed to HIV from 
January 2008 to September 2009. 
25. Rate of newborns receiving ARV treatment according to national 
guidelines 
g. Numerator # number of children prenatally exposed to HIV  that 
receive treatment according to national guidelines 
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h. Denominator # of live births prenatally exposed to HIV born 
between January 2008 and September 2009 
26. Rate of seroreversion 
i. Numerator # of children that seroconverts among prenatally 
exposed to HIV  that receive treatment according to national 
guidelines 
j. Denominator # of live births prenatally exposed to HIV born 
between January 2008 and September 2009  
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CHAPTER FOUR: RESULTS 
 
 The bulletins of epidemiological surveillance of the Ministry of Health 
reported there were 153 HIV/AIDS pregnant women in the Republic of 
Panama between January 01, 2008 and December 31, 2008 (Epidemiology, 
2011). 
During the data collection phase all 290 existing clinical charts were 
reviewed. In the antiretroviral clinics there were 116 clinical charts belonging 
to women who were pregnant and living with HIV/AIDS in 2008 and 174 
from prenatally exposed children. From the reviewed clinical charts 61 
(39.87%) of the pregnant women or girls charts include the information 
regarding the 2008 pregnancy as were 170 (97.70%) from the prenatally 
exposed children and were subject to further analysis. Each clinical chart 
represents a case; clinical charts from children whose mother’s clinical chart 
was not found were not excluded. 
 Socio-demographic characteristics among 2008 pregnant women living 
with HIV/AIDS are shown in Table 3. The study found that pregnant women 
living with HIV/AIDS are distributed mostly at Colon health region (32.03%), 
followed by the Metropolitan health region (24.84%), San Miguelito health 
region (19.30%), and Panama-west health region (9.15%). The remaining  
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health regions reported less than two percent of the cases each. The 
educational level was missing in 47.37% of the clinical charts, in 28.07% of 
the 2008 pregnant women living with HIV/AIDS had education level for more 
than ten years of education, 21.05% received from five to ten years of 
education and 3.51% of the cases received less than four years of education. 
In examining the age distribution of pregnant women and girls cases with 25 
years or younger represents 8.20%, 11.47% of the women were between 26 
and 29 years and 50.82% of the women were 30 years old or above.     
The proportion of women in the study who knew their HIV status prior 
to becoming pregnant was 38.33%, 3.33% of charts were missing the date 
of diagnosis and 58.33% of the women were diagnosed during their 2008 
pregnancy.  The proportion of pregnant women or girls that tested positive 
for HIV before the 20th week of gestation were 50%, 38.33% tested positive 
after the 20th week of gestation, and 11.67% of the cases did not report the 
date of diagnosis (Table 4). 
Table 3. Socio-demographical description pregnant women living with 
HIV/AIDS in the Republic of Panama between January 01, 2008 and 
December 31, 2008.  
Variable  N Percentage 
Health regions    
 Bocas del Toro 4 2.61% 
 Cocle - - 
 Colon 49 32.03% 
 Chiriqui 3 1.96% 
 Darien 1 0.65% 
 Gnobe Bugle 2 1.31% 
 Guna Yala 3 1.96% 
 Herrera - - 
 Los Santos 1 0.65% 
 Panama-East 1 0.65% 
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 Panama- Metropolitan 38 24.84% 
 Panama-West 14 9.15% 
 San Miguelito 28 18.30% 
 Veraguas  5 3.27% 
 Missing 4 2.61% 
 
Educational level 
Total 153 100.00% 
 Less than four years 2 3.51% 
 Five to ten years 12 21.05% 
 More than ten years 16 28.07% 
 Missing 27 47.37% 
 Total 57 100.00% 
Age ranges    
 <= 25 years 5 8.20% 
 26 - 29 years 7 11.47% 
 >= 30 years 31 50.82% 
 Missing  18 29.51% 
 Total 61 100.00% 
 
 
 The start date of prenatal control among pregnant women or girls 
living with HIV/AIDS in 2008 is missing from the clinical charts in 63.79% of 
the women. The prenatal control was initiated during the first and second 
trimester in 15.52% of women, and 5.17% of women started their prenatal 
control during the third trimester. 
The proportion of pregnant women and girls with an HIV positive 
diagnosis who received counseling regarding sexually transmitted diseases 
was 53.33%. The provision of condoms among pregnant women or girls 
living with HIV/AIDS was reported in 47.46% of the cases, 6.78% refused to 
accept condoms, and in 45.76% of the clinical charts the information was not 
available (Table 4).  
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Table 4. Prenatal history among pregnant women living with HIV/AIDS in the 
Republic of Panama between January 01, 2008 and December 31, 2008. 
Variable  N Percentage 
Prior HIV diagnosis    
 Yes 23 38.33% 
 No 35 58.33% 
 Missing 2  3.33% 
 Total 60 100.00% 
Variable  N Percentage 
Start of prenatal 
control  
   
 First Trimester (0-13w) 9 15.52% 
 Second Trimester (14-27w) 9 15.52% 
 Third trimester (28-41w) 3 5.17% 
 Missing 37 63.79% 
 Total 58 100.00% 
Tested HIV positive    
 Before 20th week 30 50.00% 
 After 20th week 23 38.33% 
 Missing 7 11.67% 
 Total 60 100.00% 
HIV and pregnancy 
counseling 
   
 Yes 32 53.33% 
 No 0 0.00% 
 Missing 28 46.67% 
 Total 60 100.00% 
Provision of condoms    
 Yes 28 47.46% 
 No 4 6.78% 
 Missing 27 45.76% 
 Total 59 100.00% 
Referred to ARVC    
 Yes 39 65.00% 
 No 19 31.67% 
 Missing 2 3.33% 
 Total 60 100.00% 
Referred to high risk 
OB-GYN unit 
   
 Yes 53 88.33% 
 No 5 8.33% 
 Missing 2 3.33% 
 Total 60 100.00% 
HAART     
 Yes 49 81.67% 
 No 9 15.00% 
 Missing 2 3.33% 
 Total 60 100.00% 
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Pregnant women and girls living with HIV/AIDS should be referred to 
antiretroviral clinics and to a high risk OB-GYN unit from the health care 
facility that made the diagnosis. The study found the reference to the ARVC 
in 65% of the clinical charts, in 31.67% the diagnosed was during labor and 
they were not referred prior delivery, and in 3.33% of the clinical charts the 
information was missing. They were referred to a high risk obstetric unit in 
88.33% of the cases, in 8.33% of the cases they were diagnosed during 
labor, and in 3.33% of the clinical charts the information was not available. 
The pregnant women and girls living with HIV/AIDS received in 81.67% of 
the cases a treatment including Lopinavir/Ritonavir, 15% of the schemes 
didn’t include it, and in 3.33% of the clinical charts the information was not 
available. 
A viral load test was requested from 86.67% (N=52) of the pregnant 
women or girls who were pregnant in 2008, and the information was missing 
in 13.33% of the cases. The results of the viral load was available prior 
delivery in 41.67% of the cases (N=25), while 46.67% of viral load results 
arrived after the birth (N=28) and in 11.67% (N=7) of the cases couldn’t be 
performed the test due to lack of laboratory materials to perform the test.  
Among the women and girls who were pregnant in 2008 and a viral load test 
result was available before birth, 68% were below 1000 viral copies 
(N=17/25), 32% were above 1000 copies, and in 4% of the cases the 
information was not recorded at the clinical chart (Table 5).  
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Table 5. Delivery characteristics among pregnant women living with 
HIV/AIDS in the Republic of Panama between January 01, 2008 and 
December 31, 2008. N=60 
Variable  N Percentage 
Viral load (VL) requested    
 Yes 52 86.67% 
 No 4 6.67% 
 Missing 4 6.67% 
 Total 60 100.00% 
VL available    
 Yes 25 41.67% 
 No 28 46.67% 
 Missing 7 11.67% 
 Total 60 100.00% 
VL <1000 copies    
 Yes 17 28.33% 
 No 26 43.33% 
 Missing 17 28.33% 
 Total 60 100.00% 
Obstetric Outcome    
 Abortion 3 5.00% 
 Miscarriage 1 1.67% 
 Stillbirth 1 1.67% 
 Live birth 50 83.33% 
 Missing 5 8.33% 
 Total 60 100.00% 
AZT during labor    
 Yes 24 40.00% 
 No 12 20.00% 
 Missing 24 40.00% 
 Total 60 100.00% 
Delivery type    
 Vaginal delivery 12 20.00% 
 Emergency caesarean 3 5.00% 
 Elective caesarean 33 55.00% 
 Missing 12 20.00% 
 Total 60 100.00% 
 
The pregnancies of the HIV positive women or girls ended with a live 
birth in 83.33% of the cases, 5% ended in abortion and both miscarriages 
and stillbirth, each representing 1.67%. The information was absent in 
8.33% of the cases. During labor 48% of the cases received intravenous 
AZT, 14% did not, and the information is not included in 38% of the clinical  
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charts. The distribution of the method of delivery was 55% with elective 
caesarean-section, 20% with vaginal delivery and 5% emergency caesarean-
section (Table 5).  
When the data regarding the prenatally exposed children was 
evaluated, the geographical distribution of the life births were 48.28% in the 
Metropolitan health region, 9.77% in the Colon health region, 8.62% West 
Panama health region, 8.39% in San Miguelito health region, in the 4.02% in 
the East Panama health region, in the 3.45% Cocle health region, 1.15% in 
the indigenous community of Gnabe Bugle, and below 1% of the cases 
nationwide in the rest of the health regions. The geographical distribution of 
the resulting HIV children was 7.47% in the metropolitan region and 1.15% 
of the cases were in the Colon, San Miguelito, Panama west region each 
(Table 6). 
Live births occurred in 84.48% of the cases in a hospital, and the 
proportion HIV positive children that were born in the hospital were 9.77%. 
Vaginal delivery was present in 37.36% of the prenatally exposed children 
and 50.58% were delivered through caesarean. Among the children that 
ended positive at the end of the follow-up period, 8.05% were delivered 
vaginally and 4.02% were delivered through caesarean. The information 
regarding the delivery method was missing in 12.07% of the cases. Among 
the prenatally exposed children the gestational age above 37 weeks was 
55.75%, and below 37 weeks 8.05%, and 36.21% of the clinical charts does 
not include the gestational age at delivery among the live births in the 
35 
 
prenatally exposed to HIV between January 2008 to September 2009. Among 
the HIV positive children secondary to prenatal exposure the gestational age 
at birth above or equal 37 weeks was 5.75%, below 37 weeks was 40.23%, 
and the information was missing in 9.75% of the cases (Table 6).  
Among the live births the weight at birth was adequate for the 
gestational age in 61.49%, 2.30% were recorded with low weight at birth, 
and the information was missing in 36.21% of the clinical charts. Within the 
HIV positive children secondary to prenatal exposure to HIV 0.57% were with 
low weight at birth, 6.32% with adequate weight at birth and the information 
was missing in 5.75% of the clinical charts. Among the children that tested 
negative at the end of the follow-up period, 1.72% were with low weight at 
birth, 43.10% were with adequate weight at birth and 18.39% of the cases 
did not include the information in the clinical chart (Table 6). 
Table 6. Distribution of characteristics of prenatally exposed children to HIV 
during January 01, 2008 and September 31, 2009 by HIV status. 
Variable  Total 
%(N) 
HIV + 
%(N) 
HIV – 
%(N) 
Missing 
Health regions      
Bocas del Toro  0.57% (1) 0.57% (1) - - 
Cocle  3.45% (6) 0.57% (1) 2.30% (4) 0.57% (1) 
Colon  9.77% (17) 1.15% (2) 8.05% (14) 0.57% (1) 
Chiriqui  - - - - 
Darien  0.57% (1) - 0.57% (1) - 
Gnobe Bugle  1.15% (2) 0.57% (1) 0 0.57% (1) 
Guna Yala  0.57% (1) - 0.57% (1) - 
Herrera  - - - - 
Los Santos  - - - - 
Panama-East  4.02% (7) - 3.45% (6) 0.57% (1) 
Panama- Metro  48.28% (84) 7.47% (13) 31.61% (55) 9.20% (16) 
Panama-West  8.62% (15) 1.15% (2) 5.75% (10) 1.72% (3) 
San Miguelito  8.39% (32) 1.15% (2) 10.34% (18) 6.90% (12) 
Veraguas   0.57% (1) - 0.57% (1) - 
Missing  4.02% (7) - - 4.02% (7) 
Total  100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
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Hospital delivery 
Yes  84.48%(147) 9.77% (17) 60.92% (106) 13.79 (24) 
No  4.02% (7) 1.15% (2) 2.30% (4) 0.57% (1) 
Missing  11.50% (20) 1.72% (3) -  9.76% (17) 
Total  100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
Method of delivery      
Vaginal 
delivery 
 37.36% (65) 8.05% (14) 23.56% (41) 5.75% (10) 
Caesarean  50.58% (88) 4.02% (7) 38.05% (67) 8.04% (14) 
Missing  12.07% (21) 0.57% (1) 1.15% (2) 10.34% (18) 
Total  100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
Gestational age  37 
weeks 
     
Yes  55.75% (97) 5.75% (10) 40.23% (70) 9.77% (17) 
No  8.05% (14) 1.15% (2) 5.17% (9) 1.72% (3) 
Missing  36.21% (63) 5.75% (10) 17.82% (31) 12.64% (22) 
Total  100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
Gestational weight 
at birth 
     
Small for gest. 
age 
 2.30% (4) 0.57% (1) 1.72% (3) - 
Adequate for 
gest. Age 
 61.49%(107) 6.32% (11) 43.10% (75) 12.07% (21) 
Missing  36.21% (63) 5.75% (10) 18.39% (32) 12.06% (21) 
Total  100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
 
Regarding the interventions to prevent mother-to-child transmission, 
58.05% of mothers received HAART during pregnancy, 32.76% did not 
receive HAART during labor, and the information was missing in 9.20% of the 
clinical charts. Among the cases that received HAART, 4.02% of the children 
were diagnosed as HIV positive and 46.55% were negative, among those 
that did not receive HAART during pregnancy, 8.62% tested positive and 
16.67% tested negative. During labor, 68.39% received intravenous AZT, 
20.11% did not receive AZT during labor, and the information was missing in 
11.50% of the clinical charts. Among the children that were diagnosed as 
HIV positive 4.60% of the mothers received AZT during labor and 7.47% did 
not receive AZT during labor, the children which final diagnosis was HIV 
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negative 51.72% receive AZT during labor and 10.92% did not receive AZT 
during labor.  
Among the prenatally HIV exposed newborns, 81.03% received oral 
AZT for the six following weeks, 6.90% didn’t receive oral AZT for the six 
following weeks after date of birth, and 12.07% of the clinical charts did not 
contain the information.  Out of the children that received oral AZT for a six 
week period, 7.47% were diagnosed positive, 59.77% were diagnosed as 
negative at the end of the follow up period, and in those children that did not 
receive oral AZT 4.60% were diagnosed as HIV positive and 1.15% as HIV 
negative. Regarding the feeding history among prenatally exposed children 
born between January 2008 and September 2009, 54.02% were fed with 
formula, 8.05% received breast milk, 6.32% received a mix between formula 
and breast milk, with the information missing in 31.61% of the clinical 
charts. Among the children that were feed formula 4.02% tested HIV 
positive, and 40.80% were diagnosed HIV negative; within those that were 
feed with breast milk, 2.87% were diagnosed as positive and 4.60% were 
diagnosed negative and those children that were feed with a mix of breast 
milk and formula 1.72% tested positive to HIV and 2.87% were diagnosed 
negative (Table 7). 
 During the 18-month follow-up period, physicians requested the first 
DNA-Pro Viral to 84.48% of prenatally exposed children to HIV, among those 
76.05% were negative, 11.98% test results were positive, and in 11.98% of   
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Table 7. Perinatal history of prenatally exposed children to HIV during 
January 01, 2008 and September 31, 2009. 
Variable  Total 
%(N) 
HIV + 
%(N) 
HIV – 
%(N) 
Missing 
Pregnant women 
w/HAART 
     
 Yes 58.05% (101) 4.02% (7) 46.55% (81) 7.47% (13) 
 No 32.76% (57) 8.62% (15) 16.67% (29) 7.47% (13) 
 Missing 9.20% (16) - - 9.19% (16) 
 Total 100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
AZT during labor      
 Yes 68.39% (119) 4.60% (8) 51.72% (90) 12.07% (21) 
 No 20.11% (35) 7.47% (13) 10.92% (19) 1.72% (3) 
 Missing 11.50% (20) 0.57% (1) 0.57% (1) 10.34 %(18) 
 Total 100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
AZT during six 
weeks 
     
 Yes 81.03% (141) 7.47% (13) 59.77% (104) 13.79% (24) 
 No 6.90% (12) 4.60% (8) 1.15% (2) 1.15% (2) 
 Missing 12.07% (21) 0.57% (1) 2.30% (4) 9.19% (16) 
 Total 100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
Feeding history      
 Breast-
feeding 
8.05% (14) 2.87% (5) 4.60% (8) 0.57% (1) 
 Formula 54.02% (94) 4.02% (7) 40.80% (71) 9.20% (16) 
 Mixed 6.32% (11) 1.72% (3) 2.87% (5) 1.72% (3) 
 Missing 31.61% (55) 4.02% (7) 14.94% (26) 12.64% (22) 
 Total 100% (174) 12.64% (22) 63.22% (110) 24.13% (42) 
 
 
the clinical charts the first DNA Pro viral test result was missing. The second 
DNA-Pro Viral test was performed in 71.84% of the cases, and 74.85% of the 
test results were negative. After the 18-month follow-up period, the ELISA 
test was negative in 65.87% of children prenatally exposed to HIV; with 
13.17% positive cases and 20.96% of the cases had not completed the lab 
tests to determine their immunological status (Table 8). Out of the 22 cases 
HIV positive, eight (36.36%) has older siblings with the same diagnosis. 
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Table 8. Laboratory progressions during the 18 month follow up period of 
prenatally exposed children to HIV during January 01, 2008 throughout 
March 31, 2011. N=167 
 PCR-1 PCR-2 ELISA  Final Diagnosis 
Positive 20  0 6 22 
Negative 127 125 98 110 
Missing 20 22 43 35 
 
 During January 01, 2008 and September 31, 2009 there were 174 
children prenatally exposed to HIV, and at the end of the 18-month follow-up 
period there were no cases of seroreversion. 
Table 9. Perinatal history of prenatally exposed children to HIV during 
January 01, 2008 and September 31, 2009 by final diagnosis. 
Variable  HIV - 
%(N) 
HIV + 
%(N) 
Total 
%(N) 
Hospital delivery     
 No 4.26 (4) 2.13 (2) 6.38 (6) 
 Yes 81.91 (77) 11.70 (11) 93.62 (88) 
 Total 86.17 (81) 13.83 (13) 100 (94) 
Method of delivery     
 Vaginal 35.11 (33) 8.51 (8) 43.62 (41) 
 Caesarean  51.06 (48) 5.32 (5) 56.38 (53) 
 Total 86.17 (81) 13.83 (13) 100 (94) 
AZT during six 
weeks 
    
 No 2.13 (2) 6.38 (6) 8.51 (8) 
 Yes 84.04 (79) 7.45 (7) 91.49 (86) 
 Total 86.17 (81) 13.83 (13) 100 (94) 
Feeding history     
 Formula 73.40 (69) 7.45 (7) 80.85 (76) 
 Breastfeeding  8.51 (8) 4.26 (4) 12.77 (12) 
 Mixed 4.26 (4) 2.13 (2) 6.38 (6) 
 Total 86.17 (81) 13.83 (13) 100 (94) 
 
 Direct interventions on the infant prenatally exposed to HIV are 
being delivered at the hospital including the method of the delivery and if the 
infant received oral zidovudine for six weeks in addition to the feeding 
history. We dropped the missing data and among the children that were born 
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at the hospital 81.91% (77) were HIV negative versus 11.70%(11) with a 
final diagnosis of HIV positive. Of those delivered by caesarean 51.06%(48) 
were HIV negative and 5.32% (5) diagnosed HIV positive. Of children that 
received oral zidovudine for six weeks 84.04% were  negative, versus 7.45% 
who ended with a positive diagnosis. Prenatally exposed children that were 
fed with formula in 73.40% of the cases ended with an HIV negative 
diagnosis versus 7.45% with an HIV positive diagnosis. (Table 9). 
 Descriptive statistics regarding the interventions to prevent 
mother-to-child HIV transmission and the outcomes on the prenatally 
exposed children of this study show that pregnant women who received 
HARRT during pregnancy, and intravenous AZT during labor is statistically 
significant to reduce the transmission rate to their offspring. If the newborn 
is delivered by caesarean, received oral treatment with zidovudine, and is fed 
exclusively with infant-adapted formula the incidence of an HIV positive 
decreases, with  statistical significance. Events such as having an older HIV 
positive sibling and being delivered outside the hospital are not significant in 
the HIV rate of the children prenatally exposed to HIV (Table 10). 
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Table 10. Descriptive statistics regarding preventing mother-to-child 
transmission interventions by outcome on the prenatally exposed children to 
HIV in the pregnancies of 2008 and their offspring’s. 
Variable 
 
HIV+ HIV- Total X² p value 
Did the pregnant women 
receive HAART? 
Yes 7 81 88     
NO 15 29 44     
Total 22 110 132 14.43 p<0.01 
              
Did the pregnant women 
receive AZT during labor? 
Yes 8 90 98     
NO 13 19 32     
Total 21 109 130 18.77 p<0.01 
       
Did the newborn was 
delivery through caesarean? 
Yes 7 67 74     
NO 14 41 55     
Total 21 108 129 5.92 p<0.05 
       
Did the newborn receive oral 
AZT first six weeks? 
Yes 13 104 117     
NO 8 2 10     
Total 21 106 127 31.68  
              
Did the newborn was feed 
with formula? 
Yes 7 71 78     
NO 8 13 21     
Total 15 84 99 10.91 p<0.01 
              
Did the prenatally exposed 
children to HIV have siblings 
HIV positive? 
Yes 1 3 4     
NO 11 74 85     
Total 12 77 89 0.4762 p>0.05 
       
The delivery was held in a 
hospital? 
Yes 17 106 123     
 NO 2 4 6     
 Total 19 110 129 1.73 p>0.05 
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CHAPTER FIVE: DISCUSSION 
 
Findings 
This study found more cases of prenatally exposed children to HIV 
than pregnant women reported living with HIV/AIDS and being pregnant 
because the screening coverage for those women or girls in 2008 was 
75.80%, the national surveillance department missed approximately one out 
of four cases for diagnosis resulting in under reporting. Because there were 
only two pediatric ARVC in the 2008-2009 period, their coverage among the 
pediatric population was higher.  According to the Summary Progress Report, 
2011, the coverage on HIV-testing in low and middle country ranges between 
8–35% (UNAIDS, 2011) which means that in this study, Panama is above its 
peer countries at 75.8% coverage.  
 Pregnant women or girls living with HIV/AIDS were located mostly at 
Colon health region (32.03%), secondly in the Metropolitan health region 
(24.84%), San Miguelito health region (19.30%), and Panama-west health 
region (9.15%). The remaining health regions reported less than two percent 
of the cases each. Coincidentally the health regions with the highest 
proportions of pregnant women or girls living with HIV/AIDS are the same 
with the highest rates of HIV nationwide (Epidemiology, 2011). 
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The distribution of pregnant women or girls living with HIV/AIDS in 
2008 according to age range in the Republic of Panama was 11.63% younger 
than 25 years old, .28% of the pregnant women were between 26 and 29 
years old and most of the cases were in the age group older than 30 years 
(72.09%). According to (Florida, et al., 2006) the age range found was 17-
32 years old, the mean was 32.2 years old, and the median 32 years. In 
Panama based on the results of this study the age group more affected is 
above 30 years old. 
Educational attainment among pregnant women living with HIV/AIDS 
in the study with more than 10 years of education was 28.08% among those 
clinical charts that included this information. Educational attainment and the 
presence of HIV has been discussed widely; the literature prior to 1996 
shows no correlation between educational level and the presence of HIV, nor 
does it show that people with higher academic degrees are at more risk of 
being HIV positive (Hargreaves, J.R.; Glynn, J.R., 2002); after the year 
2000, studies show less risk with higher educational attainment (Hargreaves, 
et al., 2008).    
 The distribution of pregnant women or girls living with HIV/AIDS 
according to the start date of prenatal control was 15.52% during each the 
first two trimesters, and 5.17% in the last trimester. Most of the clinical 
charts did not have this information available. Compared with available 
literature most of the pregnant women living with HIV/AIDS start their 
prenatal control during the first trimester (57.6%), followed by the second 
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trimester (26.3%), and there are fewer diagnoses during the third trimester 
(16.1%) (Florida, et al., 2006). 
The distribution of HIV positive tests performed in pregnant women or 
girls was 50% before the 20th weeks of pregnancy and 38.33% after 20 
weeks. International HIV screening guidelines mention the relevance of 
having the diagnosis as early as possible to avoid vertical transmission (CDC, 
2006). Based on the findings of this study, there is not a clear trend in the 
early diagnosis of HIV during pregnancy. 
The absence of prenatal counseling about HIV for pregnant women or 
girls was reported in the clinical charts reviewed for this study at 35.6% in 
Italy (Florida, et al., 2006), and in 30% in the United States of America 
(Mofenson, 2000). In this study conducted in the Republic of Panama the 
absence of counseling for HIV was found at 46.67% which is above the 
proportion reported in the literature.  
Pregnant HIV positive women or girls were referred to the ARVC in 
65% of the cases, 31.67% were not referred, and in 3.33% of the clinical 
charts the information was missing. They were referred to a high risk 
obstetric unit in 88.33% of the cases, in 8.33% of the cases they were not 
referred, and in 3.33% of the clinical charts the information was not 
available. The proportion of women referred to ARVC is lower than the one 
expected in the Panamanian health system, which established a serious of 
interventions to warranty free access to prenatal care among pregnant 
women living in the Republic of Panama (Ministry of Health, 2000). 
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The proportion of pregnant women or girls who previously knew their 
HIV diagnosis was at least 38.33%.  
According to the World Health Organization the proportion of pregnant 
women or girls living with HIV/AIDS that receive treatment including 
Lopinavir/Ritonavinar in low to middle income countries is 33% (Wilcher & 
Cates, 2009); this study found that 81.67% of the pregnant women or girls 
living with HIV/AIDS received proper treatment according to national 
guidelines during January 1, 2008 until December 31, 2008, which is greater 
than the peer countries. 
The distribution of the obstetric outcome among pregnant women 
living with HIV/AIDS reported from live births between January 2008 and 
September 2009 was 83.33% ending in a live birth, 5.00% of the cases were 
abortions, and 1.67% were stillbirths, and 1.67% were miscarriages. The 
literature reveals that 0.033% of pregnant women living with HIV/AIDS 
experienced a stillbirth (DIGEST, 2008) with a range between 2%-8%. 
Panama’s proportion regarding stillbirth is below that reported in the current 
literature. In low and middle income countries, the proportions of live births 
has been reported as 36% (Massad, et al., 2004), Panama presents more 
than twice that value. Abortions are reported in approximately one out of 
four pregnancies among HIV positive women or girls (Massad, et al., 2004). 
In the current study, 5% of the pregnancies in women living with HIV/AIDS 
during 2008 ended in an abortion, which is below what has been reported in 
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the available literature. This might be related to under-report of the cases 
because abortion is illegal in Panama.   
Among the 174 HIV seropositive pregnant women or girls who 
presented a live birth between January 2008 and September 2009, 40.63% 
(n=65) were vaginal deliveries, 34.38% (n=55) were emergency caesarean-
sections and 20.63% (n=33) were elective caesarean-sections. There were 
seven clinical charts without the delivery method and 14 missing files. The 
delivery mode in recent studies shows that elective caesarean-sections are 
present in 51% of pregnant women or girls living with HIV/AIDS, 34% are 
vaginally deliveries (European Collaborative Study, 2010). The current study 
reveals scheduled caesareans are less frequent than what is recommended 
and what happens in peer countries.   
The proportion of gestational age at birth among those prenatally 
exposed to HIV between January 2008 to September 2009 was above 37 
weeks of gestation 60.63% (n=97), below 37 weeks was 8.75% (n=14), 49 
files did not include the information, and there were 14 missing files. Most of 
the cases reported in this study were above 37 weeks, despite literature 
describes prematurity related to HIV/AIDS (Sibiude, et al., 2012). 
The distribution of birth weight among those live births of the 
prenatally exposed to HIV between January 2008 to September 2009 was 
61.49% (n=107) with adequate birth weight and 2.30% with low weight for 
gestational age; in 36.21% of the cases the information was missing in the 
clinical charts. Current literature describes low weight at birth present in 
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children born from HIV women at 29% (Markson, et al., 1996), a much 
higher proportion than the one reported in the current study (2.30%) and it 
might be result of the missing data related to this question. 
The proportion of newborns receiving prophylaxis treatment according 
to national guidelines to prevent mother-to-child transmission of HIV was 
81.03%, while 6.90% did not receive oral AZT for the six weeks after birth, 
and 12.07% of the clinical charts did not contain the information.  According 
to UNAIDS’s report, 42% of the newborns prenatally exposed to HIV received 
prophylaxis in low–middle income countries such as Panama (38%-48%) 
(UNAIDS, 2011). This study shows that Panama provides twice the 
percentage in comparison with its peer countries regarding prophylaxis 
coverage against HIV.  
Regarding the feeding history among prenatally exposed children born 
between January 2008 and September 2009, 58.75% were fed with formula, 
8.75% received breast milk exclusively, 6.88% received a mix between 
formula and breast milk and the information was missing in 25.63% of the 
clinical charts. In low-middle income countries the proportion of HIV positive 
women and girls that breastfeed their offspring were 21.42%, provide 
formula were 28.49%, and children that were fed with a mix between breast 
milk and formula were 50.09% (Coutsoudis, et al., 2001). This study reveals 
that prenatally exposed children are fed mostly with formula-adapted milk in 
Panama than its peer country (58.75% vs. 21.42%). Between 56% and 76% 
of prenatally exposed children to HIV were fed in Africa exclusively with 
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breast milk (Bork, et al., 2013), in the Republic of Panama 8.75% of the 
children are fed with breast milk which is lower than expected in peer 
countries.  
At the end of the 18-month follow-up period, 13.17% of the prenatally 
exposed children were positive for HIV, 65.87% were negative, and 20.96% 
of the cases had not completed the lab tests to determine their 
immunological status. Compared with others low-middle income countries 
the vertical transmission rate with PMTCT is 3.5%, which means that 
Panamanian prenatally exposed children to HIV have four times more risk of 
becoming HIV positive. The World Health Organization goal of 5–15% 
transmission rate with ARVT and no breastfeeding intervention (Shaffer, 
2010). It is important to mention that if a children DNA-Pro viral results are 
positive the confirmatory test is RNA Pro viral test which count viral load. 
The interventions to prevent mother-to-child HIV transmission that 
were statistical significant in this study were the used of HARRT during 
pregnancy (0.000146<0.05), the use of intravenous AZT during labor 
(1.5x10-5<0.05), being delivered by caesarean (0.014948<0.05), received 
oral treatment with zidovudine for six weeks (null<0.05), and being feed 
exclusively with infant-adapted formula (0.000954<0.05). This interventions 
has been described as protective factors by the World Health Organization 
(World Health Organization, 2010), Pan-American Health organization (Pan-
American Health Organization, 2010) and studies that promote the use of 
zidovudine during pregnancy (National Institutes of Health, 1996). The 
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overall reduction of mother-to-child HIV transmission with the 
aforementioned strategies is up to 50%, with a transmission rate below 5%. 
Missing data 
 The current study showed a high rate of under report, especially in 
pregnant women and girls clinical charts. The national surveillance 
department missed 24.20% of the cases, and the antiretroviral therapy 
clinics missed 24.18% which is consistent the local level versus the national 
level. Out of the existing clinical charts 47.71% provided only minimum 
registration information and it was recorded the antiretroviral therapy clinic 
lost to follow up due to lack of response of the pregnant women or girl 
rendering them excluded from the study. Only health region and age 
information was collected from the cases reported at the national 
epidemiology department because there is no other information relevant to 
this research. At the ARVC 60.00% of the cases were missing files or the 
information regarding a pregnancy in 2008 was not included. Because of the 
amount of missing data, especially among the clinical charts belonging to 
pregnant women living with HIV/AIDS, the information only reflects the 
reality of the women included in the study. Health care personnel need to be 
more conscious about the relevance of the quality of the data input in the 
clinical charts rather just to be focused on the quality of the health care 
provision.  
The progress in any epidemic is measured by monitoring indicators, 
which need to reflect the quality of the service provided in the clinic. To 
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improve the quality of the reports, we need to decrease the amount of 
missing data. To do so we will need to perform exploratory qualitative 
research to identify potential threats at the individual, interpersonal and 
organizational level. Based on those threats then develop interventions to 
engage health care personnel to achieve a common goal of better quality of 
the service provided, and better data quality to improve the quality of 
national reports. To address the obstacles at the individual level the 
Transtheoretical model will be helpful in recognizing the rationalization of 
highly skilled health care personnel. Monitoring their activities by their peers 
will help to maintain certain behavior. At the interpersonal level it would be 
relevant to work with the social cognitive theory because it is dynamic, and 
multidimensional, similar to the relationship between different health care 
providers involved in the care of pregnant women living with HIV/AIDS and 
newborns exposed to HIV. Lastly, to overcome the obstacles within the 
health care system, the organizational culture theory explains, the effort to 
engage all co-workers on the values of the organization with a dynamic 
definition constructed by the personnel involved in taking care of such 
patients (Coreil, 2010) (Green & Kreuter, 2005).  
 To look at the accuracy and the quality of the sources of the 
information the study performed analysis to compare the amount of data 
input among the variables the use of HAART during pregnancy, the use of 
intravenous AZT during labor and the caesarean delivery method by health 
region. The sources compared were the clinical charts form pregnant women 
and from the newborns (Table 11). Clinical charts belonging to live births  
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from HIV women that were pregnant in 2008 had less missing information 
than the clinical charts from the pregnant HIV women or girl from 2008. The 
information reported within the clinical charts of the children was similar 
among the three variables collected from the clinical charts, which can be 
interpreted as consistent information from the prenatally exposed children to 
HIV. The information in the clinical charts from the pregnant women does not 
have the same proportion along the three variables, and can be interpret as 
not consistent.  The information from Cocle, Panama-east and San miguelito 
health regions is similar along the clinical charts from the 2008 pregnant 
women living with HIV/AIDS and the newborns prenatally exposed to HIV. 
Colon and Panama-metropolitan are the health regions with the biggest 
information gap between the three variables compared from the clinical 
charts in this study.   
Table 11. Comparison of data input per health region by variable among the 
clinical charts reviewed from pregnant women or girls living with HIV/AIDS in 
2008 and newborns from women who were pregnant and HIV positive in 
2008. 
 
Number of 
cases 
Received HAART 
during pregnancy 
Received  
Intravenous AZT 
during labor 
Caesarean 
Delivery method 
 P LB P LB P LB P LB 
Bocas del Toro 4 1 - - - - - - 
Cocle - 6 1.64% 1.72% - 1.72% 1.64% 1.72% 
Colon 49 17 52.46% 7.47% 34.43% 7.47% 40.98% 7.47% 
Chiriqui 3 - - - - - - - 
Darien 1 1 - - - - - - 
Gnobe Bugle 2 2 - - - - - - 
Guna Yala 3 1 - - - - - - 
Herrera - - - - - - - - 
Los Santos 1 - - - - - - - 
Panama-East 1 7 1.64% 2.30% - 2.30% 1.64% 2.30% 
Panama-Metro 38 84 9.84% 31.61% 3.28% 37.93% 4.92% 26.44% 
Panama-West 14 15 3.28% 6.32% - 5.75% - 3.44% 
San Miguelito 28 32 9.84% 8.05% - 12.64% 8.20% 8.62% 
Veraguas  5 1 - 0.57% - 0.57% - 0.57% 
Missing 4 7 4.92% 9.20% 40.98% 11.50% 21.31% 12.07% 
Total 153 174 83.62% 67.24% 78.69% 79.88% 78.69% 53.44% 
Note: P= Pregnant women or girl, LB= Live birth 
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Study Limitations 
The national coverage of screening for HIV and syphilis in 2010 among 
pregnant women and girls has a mean of 74.9% (with ranges between 
23.0% for indigenous communities like Gnabe bugle and up to 94.2 % in the 
indigenous community of Guna Yala) which make it difficult to identify 
pregnant women living with HIV/AIDS between January 1, 2008 and 
December 31, 2008. Because the national screening service during 2008 was 
low there was an under-report of pregnant women or girls living with 
HIV/AIDS during that year, but later on, pediatric health services in the 
Republic of Panama were able to find more prenatally exposed children than 
pregnant mothers HIV positive during 2008.  
This study was based on a secondary source of information such as the 
epidemiological bulletins from the national epidemiological surveillance for 
STD/HIV/AIDS department from the Ministry of Health, relying in the 
accuracy of the data such as name and identification numbers. When the 
clinical charts were reviewed, there were with different identification numbers 
or names, which made it difficult to locate them.  
The clinical charts from the ARV clinics of each health region, the 
national ARV clinic for children located at the children’s hospital, and an NGO 
“Albergue de Maria” which cares for orphans were incomplete. The largest 
amount of missing data was found in the adult’s antiretroviral clinics.  
The procedure to triangulate the pediatric cases with the pregnant 
women cases in the adult ARV clinics was not possible because during the 
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first half of 2008 in the pediatric clinical chart the identification number of the 
mother was not listed. The study tried to triangulate by the birth date, but in 
most of the mothers, clinical charts the birth date was not available. Based 
on the previous limitation the study could not follow the complete cycle for all 
of the cases. 
In Panama the diagnosis algorithm includes a RNA viral test once a 
prenatal exposed child tested positive for HIV, to account the viral load in 
plasma. Late seroreversion cases (children that tested positive in their DNA 
por-viral test and negative after 12 month follow-up period) were not found 
in the current study because of the current national algorithm which is a 
limitation of the study. 
The information regarding Syphilis cases was not available in a timely 
manner to include them in the current study. 
Conclusions 
The Republic of Panama has made efforts to reduce Mother-to-Child 
HIV transmission, such as development of legislation to mandatory 
notification of pregnant women and girls with the HIV positive diagnsosis, as 
well as to provide medical service free of charge for pregnant women during 
prenatal control and labor, and designing the national guidelines to prevent 
vertical transmission of HIV and Congenital Syphilis. The current study shows 
the improvements on certain topics such as the availability of treatment, the 
proper usage of medications to avoid mother-to-child HIV transmission, 
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laboratory tests to diagnose mothers and children, and the free provision of 
formula-adapted milk.  
The study shows opportunities for improvement such as the late start 
date of prenatal control, the uncertainty of HIV screening pregnant women 
during the first 20 weeks of gestation, because the earliest the HIV positive 
diagnosis is made, the earliest the onset of treatment that will decrease the 
risk of mother-to-child HIV transmission. The screening with non-treponemic 
tests which is an inexpensive screening test use as a predictor of sexual risk 
behavior, and ending the pregnancy with viral load results available which 
will help the health care personnel to decide the delivery method of the 
pregnant women.  
  
Recommendations 
 It is necessary to strengthen the surveillance system to increase the 
number of cases identified by HIV screening of pregnant women or 
girls, with the aim of measuring the impact of the interventions 
already drafted by the Panamanian government and clinical guidelines 
to avoid mother-to-child HIV transmission and Congenital Syphilis 
(World Health Organization, 2010). 
 Increase access to family planning counseling for women living with 
HIV/AIDS in reproductive ages and their couples (World Health 
Organization, 2010).  
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 Evaluate if it is cost-effective that pregnant women living with 
HIV/AIDS shall continue ARVT after delivery (UNICEF, 2012).  
 In order to improve the quality of the information obtained from the 
clinical charts it is necessary to decrease the amount of missing data 
and non-available information. It is necessary to explore the reasons 
why the health care personnel are not documenting adequately the 
information of pregnant women and girls living with HIV/AIDS. Once 
the exploratory research is conducted it will be necessary to draft an 
awareness campaign to promote adequate data input in clinical charts, 
systematic collection and processing of data that will leverage the 
evidence-based decision making by the Panamanian stakeholders 
(Gliklich & Dreyer, 2010). 
 Further quantitative and qualitative research is necessary to design a 
comprehensive health program focus on the sexual health and 
reproductive rights of the HIV positive population.  
56 
 
 
 
 
REFERENCES 
 
American Academy of Pediatrics. (2012). Red Book: 2012 Report of the 
Committee on Infectious Diseases. Pickering LK,. Elk Grove Village: 
American Academy of Pediatrics. 
Bork, K., Cames, C., Cournil, A., Musyoka, F., Ayassou, K., Naidu, K., . . . 
Group, K. B. (2013). Infant feeding modes and determinants among 
HIV-1-infected African Women in the Kesho Bora Study. J Acquir 
Immune Defic Syndr, 109-118. 
CDC. (2006). Revised recommendations for HIV testing of adults, 
adolescents, and pregnant women in health-care settings. Atlanta: 
MMWR. 
Coutsoudis, A., Pillay, K., Kuhn, L., Spooner, E., Tsai, W., Coovadia, H., & 
Group., S. A. (2001). Method of feeding and transmission of HIV-1 
from mothers to children by 15 months of age: prospective cohort 
study from Durban, South Africa. AIDS, 379-387. 
Department of Epidemiology. (2010). Sexually transmitted diseases report. 
Panama: Ministry of health. Informe de la situacion de infecciones de 
transmision sexual. Panama: Ministerio de Salud. 
DIGEST. (2008). HIV May Not Increase Risk of Stillbirth Among Women in 
Sub-Saharan Africa. International Family Planning Perspectives, 53-54. 
Epidemiology, D. o. (2011). Cummulative report about HIV/AIDS 1984-
2010.Panama:Ministry of Health. Informe acumulativo de la situacion 
de VIH/SIDA 1984-2010. Panama: Ministerio de Salud. 
European Collaborative Study. (2010). Mode of delivery in HIV-infected 
pregnant women and prevention of mother-to-child transmission: 
changing practices in Western Europe. HIV Med., 368–378. 
 
57 
 
Florida, M., Ravizza, M., Tamburrini, E., Anzidei, G., Tibaldi, C., Maccabruni, 
A., . . . Ferazzi, E. (2006). Diagnosis of HIV infection in pregnancy: 
data from a national cohort of pregnant women with HIV in Italy. 
Epidemiology and Infection, 1120–1127. 
Gliklich, R., & Dreyer, N. (2010). Registries for Evaluating Patient Outcomes: 
A User's Guide, 2nd edition. Rockville: Agency for Healthcare Research 
and Quality. Retrieved June 14, 2013, from 
http://www.ncbi.nlm.nih.gov/books/NBK49444/ 
Gray, R., Wawer, M., Brookmeyer, R., Sewankambo, N., Serwadda, D., 
Wabwire-Mangen, F., & Lutalo, T. (2001). Probability of HIV-1 
transmission per coital act in monogamous, heterosexual, HIV-1 
discordant couples in Rakai, Uganda. Lancet, 1149-1153. 
Hargreaves, J., Bonell, C., Boler, T., Boccia, D., Birdthistle, I., Fletcher, A., . . 
. Glynn, J. (2008). Systematic review exploring time trends in the 
association between educational attainment and risk of HIV infection in 
sub-Saharan Africa. AIDS, 403–414. 
Hargreaves, J.R.; Glynn, J.R. (2002). Educational attainment and HIV-1 
infection in developing countries: a systematic review. Tropical 
Medicine and International Health, 489–498. 
Markson, L., Turner, B., Houchens, R., Silverman, N., Cosler, L., & Takyi, B. 
(1996). Association of Maternal HIV Infection with Low Birth Weight. 
Journal of Acquired Immune Deficiency Syndromes & Human 
Retrovirology, 227-234. 
Massad, L., Springer, G., Jacobson, L., Watts, H., Anastos, K., Korn, A., . . . 
Minkoff, H. (2004). Pregnancy rates and predictors of conception, 
miscarriage and abortion in US women with HIV. AIDS, 281-286. 
Ministry of Health. (1947). Sanitary code of the Republic of Panama. Law N. 
66 November 10, 1947. G.O 10467. Panama. 
Ministry of Health. (2000). General legislation about Sexually Transmitted 
Diseases, Human Immunodeficiency Virus and Acquired 
Immunodeficiency Disease. Law N. 3 of January 05, 2000. G.O. 23964. 
Panama. 
Ministry of Health. (2003). Rights and Obligations of the patients concerning 
information, free decision making and informed consent. Law N. 68 of 
November 20, 2003. Panama: G.O. 24935. 
58 
 
Mofenson, L. (2000). Technical Report: Perinatal Human Immunodeficiency 
Virus Testing and Prevention of Transmission. Pediatrics, 1-12. 
National Institutes of Health. (1996). AIDS Clinical Trial Group Study 076.  
Pan-American Health Organization. (2010). Regional Initiative for the 
Elimination of Mother-to-Child Transmission of HIV and Congenital 
Syphilis in Latin America and the Caribbean: Regional Monitoring 
Strategy”. Washington, D.C.: PAHO. 
Pan-American Health Organization. (2011). Recomendaciones técnicas para 
la elaboración de protocolos para ESTUDIOS DE PREVALENCIA DE 
SÍFILIS Y VIH EN PARTURIENTAS y/o PUERPERAS. Washington: PAHO. 
PTMI, C. I. (2010). Multisectoral plan to prevent mother-to-child transmision 
of HIV and congenital Syphilis 2009-2014. Panama: Ministry of Health. 
Plan Nacional Multisectorial para la Prevención de la Transmisión 
Materno Infantil en VIH y Sífilis 2009 -2014. Panama: Ministerio de 
Salud. 
Quetel, C. (1992). History of Syphilis. Paris, France: Polity Press. 
Shaffer, N. (2010). Use of Antiretroviral Drugs for treating pregnant women 
and preventing HIV infections in Infants. WHO 2010 Revised 
guidelines. World Health Organization. 
UNAIDS. (2011). HIV/AIDS Summary Report. Washington, D.C.: UNAIDS. 
UNAIDS. (2011). Report on the Global AIDS epidemic. Joint United Nations 
Programme on HIV/AIDS (UNAIDS). 
UNAIDS. (2011). Unaids data tables | 2011. Joint United Nations Programme 
on HIV/AIDS (UNAIDS). 
UNICEF. (2012). Options B and B plus: Key considerations for countries to 
implement an equity focused approach. UNICEF. 
USAID-PASCA. (2008). Measurement and analysis of expenditure in AIDS. 
Panama: USAID-PASCA. Medicion y Analsis del Gasto en SIDA. 
Panama: USAID-PASCA. 
Wilcher, R., & Cates, W. (2009). Reproductive choices for women with HIV. 
World Health Organization. 
59 
 
World Health Organization. (2010). PMTCT Stategic Vision 2010-2015: 
preventing mother-to-child transmission of HIV to reach the UNGASS 
and Millennium Development Goals. Switzerland: WHO. 
World Health Organization. (2010). PMTCT strategic vision 2010–2015 : 
preventing mother-to-child transmission of HIV to reach the UNGASS 
and Millennium Development Goals. Switzerland: WHO. 
World Health Organization. (2011). Towards the elimination of mother-to-
child transmission of HIV. Switzerland: WHO, UNICEF, UNFPA, 
UNAIDS. 
 
  
60 
 
 
 
APPENDICES 
  
61 
 
 
Appendix A: Institutional Review Board 
 
